Ameriprise’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $81.4M | Sell |
532,554
-37,168
| -7% | -$5.7M | 0.02% | 638 |
|
|
2025
Q4 | $78.5M | Sell |
569,722
-14,931
| -3% | -$1.96M | 0.02% | 651 |
|
|
2025
Q3 | $75M | Sell |
584,653
-46,478
| -7% | -$5.67M | 0.02% | 682 |
|
|
2025
Q2 | $76.4M | Buy |
631,131
+244,037
| +63% | +$27.5M | 0.02% | 666 |
|
|
2025
Q1 | $43.3M | Buy |
387,094
+36,131
| +10% | +$3.85M | 0.01% | 912 |
|
|
2024
Q4 | $34.1M | Sell |
350,963
-73,865
| -17% | -$7.88M | 0.01% | 1047 |
|
|
2024
Q3 | $48.9M | Sell |
424,828
-22,846
| -5% | -$2.59M | 0.01% | 858 |
|
|
2024
Q2 | $47.7M | Buy |
447,674
+18,132
| +4% | +$1.82M | 0.01% | 822 |
|
|
2024
Q1 | $41.6M | Buy |
429,542
+64,829
| +18% | +$6.65M | 0.01% | 895 |
|
|
2023
Q4 | $36.8M | Sell |
364,713
-12,336
| -3% | -$1.19M | 0.01% | 920 |
|
|
2023
Q3 | $38.4M | Sell |
377,049
-46,338
| -11% | -$4.7M | 0.01% | 870 |
|
|
2023
Q2 | $42.8M | Buy |
423,387
+9,632
| +2% | +$963K | 0.01% | 830 |
|
|
2023
Q1 | $38.1M | Sell |
413,755
-154,542
| -27% | -$13.5M | 0.01% | 889 |
|
|
2022
Q4 | $51.6M | Sell |
568,297
-76,390
| -12% | -$6.43M | 0.02% | 716 |
|
|
2022
Q3 | $49M | Sell |
644,687
-66,093
| -9% | -$5.48M | 0.02% | 712 |
|
|
2022
Q2 | $60.1M | Sell |
710,780
-766,267
| -52% | -$67.2M | 0.02% | 649 |
|
|
2022
Q1 | $130M | Buy |
1,477,047
+129,010
| +10% | +$11.2M | 0.04% | 443 |
|
|
2021
Q4 | $118M | Sell |
1,348,037
-66,951
| -5% | -$5.56M | 0.03% | 507 |
|
|
2021
Q3 | $116M | Sell |
1,414,988
-313,799
| -18% | -$28.2M | 0.04% | 475 |
|
|
2021
Q2 | $158M | Buy |
1,728,787
+3,619
| +0.2% | +$322K | 0.05% | 387 |
|
|
2021
Q1 | $147M | Sell |
1,725,168
-27,982
| -2% | -$2.51M | 0.05% | 372 |
|
|
2020
Q4 | $166M | Buy |
1,753,150
+637,848
| +57% | +$55.7M | 0.06% | 332 |
|
|
2020
Q3 | $97.1M | Sell |
1,115,302
-53,513
| -5% | -$4.64M | 0.04% | 429 |
|
|
2020
Q2 | $102M | Sell |
1,168,815
-38,000
| -3% | -$3.28M | 0.04% | 386 |
|
|
2020
Q1 | $99.4M | Sell |
1,206,815
-3,559
| -0.3% | -$318K | 0.05% | 332 |
|
|
2019
Q4 | $115M | Buy |
1,210,374
+183,560
| +18% | +$16.5M | 0.05% | 367 |
|
|
2019
Q3 | $89.2M | Sell |
1,026,814
-28,301
| -3% | -$2.54M | 0.04% | 444 |
|
|
2019
Q2 | $96.3M | Sell |
1,055,115
-125,461
| -11% | -$10.6M | 0.04% | 432 |
|
|
2019
Q1 | $102M | Buy |
1,180,576
+12,467
| +1% | +$1M | 0.05% | 404 |
|
|
2018
Q4 | $89.8M | Buy |
1,168,109
+73,767
| +7% | +$5.74M | 0.04% | 404 |
|
|
2018
Q3 | $106M | Buy |
1,094,342
+58,720
| +6% | +$4.34M | 0.04% | 444 |
|
|
2018
Q2 | $70.1M | Buy |
1,035,622
+26,313
| +3% | +$1.82M | 0.03% | 521 |
|
|
2018
Q1 | $73.2M | Sell |
1,009,309
-59,937
| -6% | -$4.56M | 0.03% | 492 |
|
|
2017
Q4 | $80.4M | Sell |
1,069,246
-24,571
| -2% | -$1.85M | 0.04% | 427 |
|
|
2017
Q3 | $84.1M | Sell |
1,093,817
-24,512
| -2% | -$1.85M | 0.04% | 407 |
|
|
2017
Q2 | $83.6M | Sell |
1,118,329
-229,705
| -17% | -$16.3M | 0.04% | 403 |
|
|
2017
Q1 | $89.8M | Sell |
1,348,034
-215,474
| -14% | -$14.4M | 0.05% | 370 |
|
|
2016
Q4 | $102M | Sell |
1,563,508
-40,450
| -3% | -$2.62M | 0.06% | 341 |
|
|
2016
Q3 | $113M | Sell |
1,603,958
-25,287
| -2% | -$1.84M | 0.06% | 313 |
|
|
2016
Q2 | $120M | Buy |
1,629,245
+31,490
| +2% | +$2.18M | 0.07% | 270 |
|
|
2016
Q1 | $104M | Buy |
1,597,755
+128,929
| +9% | +$8.77M | 0.06% | 296 |
|
|
2015
Q4 | $113M | Sell |
1,468,826
-28,112
| -2% | -$2.23M | 0.07% | 276 |
|
|
2015
Q3 | $123M | Sell |
1,496,938
-412,005
| -22% | -$36.7M | 0.08% | 250 |
|
|
2015
Q2 | $168M | Buy |
1,908,943
+44,185
| +2% | +$4.05M | 0.1% | 214 |
|
|
2015
Q1 | $165M | Buy |
1,864,758
+35,647
| +2% | +$3.16M | 0.09% | 221 |
|
|
2014
Q4 | $152M | Buy |
1,829,111
+25,253
| +1% | +$2.09M | 0.09% | 236 |
|
|
2014
Q3 | $152M | Buy |
1,803,858
+15,411
| +0.9% | +$1.25M | 0.09% | 234 |
|
|
2014
Q2 | $145M | Sell |
1,788,447
-5,369
| -0.3% | -$422K | 0.09% | 236 |
|
|
2014
Q1 | $137M | Buy |
1,793,816
+405,367
| +29% | +$29.5M | 0.08% | 248 |
|
|
2013
Q4 | $100M | Buy |
1,388,449
+143,539
| +12% | +$9.98M | 0.06% | 320 |
|
|
2013
Q3 | $85.6M | Sell |
1,244,910
-158,265
| -11% | -$10.5M | 0.06% | 355 |
|
|
2013
Q2 | $88.9M | Buy |
+1,403,175
| New | +$91.3M | 0.06% | 347 |
|
Other funds holding NVS
Ameriprise's NVS Position: Q1 2026 in Review
Ameriprise reduced its Novartis (NVS) stake by 6.5% in Q1 2026, selling an estimated $5.7M and leaving 532,554 shares worth $81.4M. The position accounts for 0.02% of the portfolio, ranked #638.
Ameriprise first reported a position in NVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $168M in Q2 2015. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Ameriprise held 532,554 shares of Novartis worth $81.4M as of Q1 2026.
- Ameriprise sold 37,168 Novartis shares in Q1 2026, an estimated $5.7M.
- Novartis made up 0.02% of Ameriprise's portfolio in Q1 2026, its #638 holding.
- Ameriprise first reported a position in Novartis in Q2 2013 and has held it in 52 quarters since.
- Ameriprise's Novartis position peaked at $168M in Q2 2015.
- 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.